Evidence map›Paper›PMID 33737313›Full record

Trial reportBritish journal of sports medicine2022

ACL reconstruction for all is not cost-effective after acute ACL rupture.

Vincent Eggerding, Max Reijman, Duncan Edward Meuffels, Eline van Es, Ewoud van Arkel, Igor van den Brand, Joost van Linge, Jacco Zijl, Sita Ma Bierma-Zeinstra, Marc Koopmanschap

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in British journal of sports medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. "Cost-effectiveness of ACL treatment is dependent on age and activity level: a systematic review".Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Vincent EggerdingOrthopedics, Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands v.eggerding@erasmusmc.nl.ORCID http://orcid.org/0000-0002-5790-0929
Max ReijmanOrthopedics, Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands.
Duncan Edward MeuffelsOrthopedics, Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands.ORCID http://orcid.org/0000-0002-5372-6003
Eline van EsOrthopedics, Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands.
Ewoud van ArkelOrthopedics, Medisch Centrum Haaglanden, Den Haag, Zuid-Holland, The Netherlands.
Igor van den BrandOrthopedics, Elisabeth-TweeSteden Ziekenhuis, Tilburg, Noord-Brabant, The Netherlands.
Joost van LingeOrthopedics, Reinier de Graaf Gasthuis, Delft, Zuid-Holland, The Netherlands.
Jacco ZijlDepartment of Orthopaedic Surgery, Sint Antonius Hospital, Nieuwegein, The Netherlands.
Sita Ma Bierma-ZeinstraDepartment of General Practice and Orthopedics, Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands.
Marc KoopmanschapInstitute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, Zuid-Holland, The Netherlands.
Erasmus MC · NLElisabeth-TweeSteden Ziekenhuis · NLMedisch Centrum Haaglanden · NLReinier de Graaf Hospital · NLSt. Antonius Ziekenhuis · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo conduct a cost-utility analysis for two commonly used treatment strategies for patients after ACL rupture; early ACL reconstruction (index) versus rehabilitation plus an optional reconstruction in case of persistent instability (comparator).

methodsPatients aged between 18 and 65 years of age with a recent ACL rupture (<2 months) were randomised between either an early ACL reconstruction (index) or a rehabilitation plus an optional reconstruction in case of persistent instability (comparator) after 3 months of rehabilitation. A cost-utility analysis was performed to compare both treatments over a 2-year follow-up. Cost-effectiveness was calculated as incremental costs per quality-adjusted life year (QALY) gained, using two perspectives: the healthcare system perspective and societal perspective. The uncertainty for costs and health effects was assessed by means of non-parametric bootstrapping.

resultsA total of 167 patients were included in the study, of which 85 were randomised to the early ACL reconstruction (index) group and 82 to the rehabilitation and optional reconstruction group (comparator). From the healthcare perspective it takes 48 460 € and from a societal perspective 78 179 €, to gain a QALY when performing early surgery compared with rehabilitation plus an optional reconstruction. This is unlikely to be cost-effective.

conclusionRoutine early ACL reconstruction (index) is not considered cost-effective as compared with rehabilitation plus optional reconstruction for a standard ACL population (comparator) given the maximum willingness to pay of 20 000 €/QALY. Early recognition of the patients that have better outcome of early ACL reconstruction might make rehabilitation and optional reconstruction even more cost-effective.

Indexed as

Anterior Cruciate Ligament InjuriesAnterior Cruciate Ligament ReconstructionChild, PreschoolCost-Benefit AnalysisHumansInfantQuality-Adjusted Life YearsRuptureTreatment Outcomeanterior cruciate ligamentexercise rehabilitationknee injuriesknee surgerysports rehabilitation programs

Identifiers

PMID33737313
PMCPMC8685656
OpenAlexW3138877417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.